Navigation Links
Sewage treatment plants may contribute to antibiotic resistance problem
Date:12/7/2011

Water discharged into lakes and rivers from municipal sewage treatment plants may contain significant concentrations of the genes that make bacteria antibiotic-resistant. That's the conclusion of a new study on a sewage treatment plant on Lake Superior in the Duluth, Minn., harbor that appears in ACS' journal Environmental Science & Technology.

Timothy M. LaPara and colleagues explain that antibiotic-resistant bacteria a major problem in medicine today are abundant in the sewage that enters municipal wastewater treatment plants. Treatment is intended to kill the bacteria, and it removes many of the bacterial genes that cause antibiotic resistance. However, genes or bacteria may be released in effluent from the plant. In an effort to determine the importance of municipal sewage treatment plants as sources of antibiotic resistance genes, the scientists studied releases of those genes at the Duluth facility.

Although the Duluth facility uses some of the most advanced technology for cleaning wastewater so-called tertiary treatment the study identified it as an important source of antibiotic resistance genes. Sampling of water at 13 locations detected three genes, for instance, that make bacteria resistant to the tetracycline group of antibiotics, which are used to treat conditions ranging from acne to sexually transmitted diseases to anthrax and bubonic plague. LaPara's team says their research demonstrates that even the most high-tech sewage treatment plants may be significant sources of antibiotic resistance genes in waterways.


'/>"/>
Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Raw Sewage a New Frontier for Scientists
2. New study reassures on heart risks of prostate cancer treatment
3. Century-old brains may hold future of treatment for mentally ill, Indiana University pathologist says
4. LSUHSC research finds many women not receiving recommended breast cancer adjuvant treatment
5. A new study suggests that a neurotransmitter might improve the treatment of cancer
6. New child-adapted Chagas disease treatment approved for registration
7. Novocure establishes initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields Therapy
8. Mayo Clinic research improves diagnosis and potential treatment of neuromyelitis optica
9. Newly established neuroscience clinical trials center could bring treatments to patients faster
10. Tumor-targeting compound points the way to new personalized cancer treatments
11. Children with HIV/AIDS falling through the cracks of treatment scale-up efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , Ginger ... Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport ... attorneys from the firm’s global Life Sciences & Medical Technology Group have been featured ...
(Date:12/8/2016)... ... 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 — ... highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) services ... Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) named ...
(Date:12/8/2016)... ... ... Vida Health, the digital health platform that pairs individuals with ... . Other investors include Nokia Growth Partners (NGP) and returning investor Aspect Ventures. Vida ... are managing chronic conditions or simply want to improve their health. Canvas ...
(Date:12/8/2016)... ... , ... Coppin Insurance Agency, an insurance and financial planning firm based in ... area, is embarking on a charity drive with the goal of providing support and ... Food Bank of Southwest Florida works to provide fresh and nutritious food free of ...
(Date:12/7/2016)... Washington,DC (PRWEB) , ... December 07, 2016 , ... ... Forum (NYLF): Medicine will have the unique opportunity to get hands-on experience ... gives high school students an immersive experience to gain invaluable, real-life medical skills ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)...  Valeant Pharmaceuticals International, Inc. (NYSE: ... positive results from a Phase 3, multicenter double-blind, ... and efficacy of IDP-118 (halobetasol propionate and tazarotene) ... Within the Phase 3 study of ... IDP-118 showed statistical significance to vehicle with a ...
(Date:12/8/2016)... , Dec. 8, 2016 True ... that brings leading-edge laboratory services and management expertise ... States , allowing more doctors and patients ... care management solutions. Logo - ... Hospital systems, under pressure to contain costs, ...
(Date:12/8/2016)... -- Information products and services provider Elsevier ... , the world,s largest abstract and citation database of peer-reviewed literature, ... from over 5,000 publishers. The new set of metrics will improve ... when to adjust a journal,s editorial strategy. ... , , CiteScore ...
Breaking Medicine Technology: